Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Iclusig
Pharma
BioNTech, Astellas, Daiichi—Fierce Pharma Asia
BioNTech bought a Novartis facility in Singapore. Astellas' CLDN18.2 drug posted a trial win. Daiichi reported positive readout for its mRNA booster.
Angus Liu
Nov 18, 2022 10:11am
In Ph+ALL trial, Takeda's Iclusig outdoes Novartis' Gleevec
Nov 17, 2022 10:27am
Novartis wins CML nod for new Gleevec follow-on Scemblix
Nov 1, 2021 6:51am
Takeda, Astellas, Everest-Providence and more—Fierce Pharma Asia
Sep 17, 2021 9:05am
Takeda will not sign off on trial which could repurpose drug
Sep 15, 2021 7:37am
Takeda, China's COVID-19 vaccines and more—FiercePharmaAsia
Dec 11, 2020 9:25am
